David M. Kendall

10.1k total citations · 3 hit papers
108 papers, 7.4k citations indexed

About

David M. Kendall is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, David M. Kendall has authored 108 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Endocrinology, Diabetes and Metabolism, 45 papers in Surgery and 26 papers in Molecular Biology. Recurrent topics in David M. Kendall's work include Diabetes Management and Research (54 papers), Diabetes Treatment and Management (38 papers) and Pancreatic function and diabetes (32 papers). David M. Kendall is often cited by papers focused on Diabetes Management and Research (54 papers), Diabetes Treatment and Management (38 papers) and Pancreatic function and diabetes (32 papers). David M. Kendall collaborates with scholars based in United States, United Kingdom and Germany. David M. Kendall's co-authors include Dongliang Zhuang, John B. Buse, Michael Trautmann, Kristin Taylor, David E.R. Sutherland, Matthew C. Riddle, Dennis Dong Hwan Kim, Julio Rosenstock, Mark Fineman and Alain Baron and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

In The Last Decade

David M. Kendall

103 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Patients With Type 2 Diabetes Treated With Metformin and a Sulfonylurea

2005 959 citations David M. Kendall et al. Diabetes Care profile →
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study

2008 862 citations David M. Kendall et al. profile →
A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia

2005 626 citations David M. Kendall, Anthony J. Zagar et al. Diabetes Care profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David M. Kendall United States	38	5.3k	3.0k	2.2k	1.0k	985	108	7.4k
Daniel Einhorn United States	27	5.8k 1.1×	1.6k 0.6×	2.0k 0.9×	738 0.7×	891 0.9×	43	7.4k
Stephen C. Bain United Kingdom	49	7.3k 1.4×	3.6k 1.2×	3.5k 1.6×	1.3k 1.3×	1.0k 1.0×	251	11.7k
C A Cull United Kingdom	6	5.8k 1.1×	1.4k 0.5×	1.6k 0.7×	543 0.5×	756 0.8×	6	7.9k
Donna Wright United Kingdom	6	5.8k 1.1×	1.4k 0.5×	1.4k 0.6×	518 0.5×	758 0.8×	9	7.9k
R R Holman United Kingdom	10	5.5k 1.0×	1.4k 0.5×	1.4k 0.6×	506 0.5×	746 0.8×	48	7.6k
Judith Fradkin United States	25	5.3k 1.0×	1.4k 0.5×	2.3k 1.0×	488 0.5×	852 0.9×	46	7.5k
Matthews United States	7	5.4k 1.0×	1.3k 0.4×	1.4k 0.6×	479 0.5×	803 0.8×	27	7.5k
Eugene Manley United States	6	5.3k 1.0×	1.3k 0.4×	1.4k 0.6×	473 0.5×	677 0.7×	13	7.2k
John P. Bantle United States	35	3.4k 0.6×	3.3k 1.1×	692 0.3×	631 0.6×	3.3k 3.4×	78	7.2k
Matteo Monami Italy	54	7.4k 1.4×	2.1k 0.7×	3.3k 1.5×	1.5k 1.4×	812 0.8×	232	10.1k

Countries citing papers authored by David M. Kendall

Since Specialization

Citations

This map shows the geographic impact of David M. Kendall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Kendall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Kendall more than expected).

Fields of papers citing papers by David M. Kendall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Kendall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Kendall. The network helps show where David M. Kendall may publish in the future.

Co-authorship network of co-authors of David M. Kendall

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Kendall. A scholar is included among the top collaborators of David M. Kendall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Kendall. David M. Kendall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

León, Diva D. De, Indraneel Banerjee, Sebastian Kummer, et al.. (2024). Dasiglucagon in Children With Congenital Hyperinsulinism Up to 1 Year of Age: Results From a Randomized Clinical Trial. The Journal of Clinical Endocrinology & Metabolism. 110(8). e2674–e2681. 1 indexed citations

Thornton, Paul, Diva D. De León, David Zangen, et al.. (2023). Dasiglucagon for the Treatment of Congenital Hyperinsulinism: A Randomized Phase 3 Trial in Infants and Children. The Journal of Clinical Endocrinology & Metabolism. 109(4). 1071–1079. 4 indexed citations

Dimsits, Jeannett, et al.. (2021). A Comparative Study of Dasiglucagon Ready-to-Use Autoinjector and Glucagon Emergency Kit During Rescue from Simulated Severe Hypoglycemia. Diabetes Technology & Therapeutics. 24(4). 231–240. 7 indexed citations

Ray, Kausik K., David M. Kendall, Zhenxiang Zhao, et al.. (2018). A multinational observational study assessing insulin use: Understanding the determinants associated with progression of therapy. Diabetes Obesity and Metabolism. 21(5). 1101–1110. 7 indexed citations

Lebrec, Jérémie, Haya Ascher‐Svanum, Yunfei Chen, et al.. (2016). Effect of diabetes on caregiver burden in an observational study of individuals with Alzheimer’s disease. BMC Geriatrics. 16(1). 93–93. 23 indexed citations

Ascher‐Svanum, Haya, Anthony J. Zagar, Dingfeng Jiang, et al.. (2015). Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis. Diabetes Therapy. 6(3). 303–316. 31 indexed citations

Fu, Haoda, Bradley Curtis, Dara P. Schuster, Andreas Festa, & David M. Kendall. (2014). Treatment Patterns Among Older Patients with Type 2 Diabetes in the United States: A Retrospective Cohort Study. Diabetes Technology & Therapeutics. 16(12). 833–839. 5 indexed citations

Anderson, Robyn, et al.. (2009). A1C predicts type 2 diabetes and impaired glucose tolerance in a population at risk: the community diabetes prevention project. Diabetology & Metabolic Syndrome. 1(1). 5–5. 6 indexed citations

Kendall, David M.. (2006). Thiazolidinediones. Diabetes Care. 29(1). 154–157. 34 indexed citations

10.

Anderson, Robyn, et al.. (2006). Integrated Tobacco Cessation Counseling in a Diabetes Self-management Training Program. The Diabetes Educator. 32(4). 562–570. 64 indexed citations

11.

Mazze, Roger S., et al.. (2004). Undetected, uncontrolled blood pressure in type 2 diabetes: self‐monitored blood pressure profiles. Blood Pressure. 13(6). 335–342. 10 indexed citations

12.

Kendall, David M. & Anne L. Peters. (2002). The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance.. PubMed. 8(20 Suppl). S635–53; quiz S654. 85 indexed citations

13.

Kendall, David M. & Richard M. Bergenstal. (2001). Comprehensive management of patients with type 2 diabetes: establishing priorities of care.. PubMed. 7(10 Suppl). S327–43; quiz S344. 39 indexed citations

14.

Kendall, David M., et al.. (1999). The use of the hypoglycaemic clamp in the assessment of pituitary function. Clinical Endocrinology. 51(6). 709–714. 4 indexed citations

15.

Gruessner, Rainer W.G., David M. Kendall, Mary Beth Drangstveit, Angelika C. Gruessner, & David E.R. Sutherland. (1997). Simultaneous Pancreas-Kidney Transplantation From Live Donors. Annals of Surgery. 226(4). 471–482. 74 indexed citations

16.

Kendall, David M. & R. Paul Robertson. (1997). PANCREAS AND ISLET TRANSPLANTATION. Endocrinology and Metabolism Clinics of North America. 26(3). 611–630. 15 indexed citations

17.

Kendall, David M. & R. Paul Robertson. (1996). Pancreas and islet transplantation in humans.. PubMed. 22(3). 157–63. 7 indexed citations

18.

Wahoff, David C., B Papalois, John S. Najarian, et al.. (1996). Islet autotransplantation after total pancreatectomy in a child. Journal of Pediatric Surgery. 31(1). 132–136. 24 indexed citations

19.

Wahoff, David C., B Papalois, John S. Najarian, et al.. (1995). Autologous Islet Transplantation to Prevent Diabetes After Pancreatic Resection. Annals of Surgery. 222(4). 562–579. 162 indexed citations

20.

Sutherland, D. E. R., et al.. (1986). Effect of Donor Source, Technique, Immunosuppression, and Presence or Absence of End -Stage Diabetic Nephropathy on Outcome in Pancreas Transplant Recipients. 7(1). 11–15. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact